The bactericidal activity of five antibiotics for Legionella micdadei was determined by the construction of time-kill curves. Erythromycin, rifampin, penicillin G, cephalothin, and gentamicin were bactericidal for L. micdadei at readily achievable concentrations. The minimal bactericidal concentrations, defined as those producing 99.9% killing within 24 h, were: erythromycin, 4.6; rifampin, 0.13; penicillin G, 0.25; cephalothin, 2.5; and gentamicin, 0.25 ,ug/ml. The ratios of the minimal bactericidal to minimal inhibitory concentrations for these antibiotics ranged from 1 to 8. Thus, the poor in vivo activity of P-lactam and aminoglycoside antibiotics against L. micdadei cannot be ascribed to a lack of killing by these agents.
Pneumonia due to Legionella micdadei (Pittsburgh pneumonia agent) was first described in 1979 (9, 12, 15) . The etiological agent was isolated by Pasculle et al. (12) and proved to be identical to the bacterium cultivated in eggs by Tatlock in 1943 (7) . Since the clinical features of pneumonia due to L. micdadei and L. pneumophila are quite similar (3) , the two diseases can be differentiated only by identification of the causative bacterium or by serological techniques. Fortunately, erythromycin and rifampin appear to be efficacious for the therapy of both Pittsburgh pneumonia and Legionnaires disease (3, 19) . There is also evidence that erythromycin and rifampin are efficacious against these legionellae in ovo and in a guinea pig infection model (5, 8, 9) .
All isolates of L. pneumophila (4, 6, (16) (17) (18) and L. micdadei (6, 10) examined thus far have been inhibited in vitro by readily achievable concentrations of chloramphenicol and the aminoglycosides, as well as erythromycin and rifampin. L. micdadei, which does not produce a P-lactamase, is also exquisitely susceptible to penicillins and cephalosporins (10) . However, antibiotics other than erythromycin and rifampin which inhibit L. micdadei and L. pneumophila in vitro have not consistently proven to be effective in vivo (5, 8, 9) . One possible explanation for these discrepancies between in vivo and in vitro results is that some antimicrobial agents which inhibit the legionellae do not kill these bacteria. To examine this possibility, we determined the bactericidal activity of five antibiotics for L. micdadei by time-kill curves.
(This work was presented in part at the 82nd standard. This standardized inoculum was diluted 1:10 with BYEB, and 1.0 ml of this dilution was added to 9.0 ml of BYEB in 25-ml flasks to produce an initial concentration of about 107 bacteria per ml. Antibiotics were then added in concentrations ranging from 0.008 to 4.0 ,Lg/ml in twofold increments, and the flasks were incubated at 35°C on the rotary shaker. Growth control flasks containing no antibiotic were included in each experiment. Before the addition of the antibiotic and at intervals up to 72 h thereafter, 0.5-ml samples were removed from each flask, including the growth Fig. 1 to 5. Killing curves with erythromycin are shown in Fig. 1 . Increasing concentrations from 0.5 to 4.0 pg/ml, the highest tested, produced a gradually increasing rate of bacterial killing by erythromycin. However, at 0.5 ,ug of erythromycin per ml, killing was observed for 48 h, but exponential growth at a rate essentially equal to that of the antibiotic-free control ensued thereafter. This same pattern was also observed at a concentration of 0.5 ,ug/ml in a second experiment. By plating the cells from this concentration onto BCYE agar containing various concentrations of erythromycin up to 50 ,ug/ml, it was shown that the bacteria which regrew at 72 h were as susceptible to erythromycin as the original inoculum.
Even the lowest concentration of rifampin tested, 0.008 ,g/ml, totally inhibited the growth of L. micdadei over the first 30 h (Fig. 2 ).
Rifampin at a concentration of 0.125 jig/ml or above was rapidly bactericidal. Late regrowth of bacteria was seen at 0.008 jig of rifampin per ml in this experiment and at 0.001 jig/ml in two other separate experiments. The bacteria which showed regrowth were resistant to 100 ,g of rifampin per ml. Thus, in these three experiments, rifampin-resistant variants were selected out by low concentrations of rifampin.
The killing curves for penicillin G (Fig. 3 ) and cephalothin (Fig. 4) were very similar. Some inhibition was seen at low levels, and increasing rates of killing were noted above 0.063 ,ug of penicillin per ml and 0.5 ,ug of cephalothin per ml.
L. micdadei was rapidly killed by relatively low concentrations of gentamicin (Fig. 5) centrations or the lower pH of the medium employed in our studies. Thus, although the measured MBCs of erythromycin and gentamicin for L. micdadei were quite low, the actual MBCs may be even lower. Erythromycin and rifampin were found to be bactericidal, as well as bacteriostatic, for L. micdadei in vitro at low concentrations. Erythromycin and rifampin were also highly effective in ovo (9) and have proven efficacious in the treatment of patients with Pittsburgh pneumonia (3, 19) . On the basis of all in vitro studies and in (9, 15) . In addition, these antibiotics failed to protect embryonated eggs against a lethal challenge of L. micdadei (9) . We conclude that the ineffectiveness of Plactam and aminoglycoside antibiotics against L. micdadei in vivo cannot be explained on the basis of a lack of bactericidal action.
Presumably, those antibiotics which are bactericidal in vitro but ineffective in vivo must not be active at the intracellular location of the legionellae. However, Bacheson and her coworkers (2) reported that gentamicin was more effective than erythromycin in killing L. pneumophila within human embryonic lung fibroblast cells. If these results are confirmed, it raises the question of whether the precise cell type(s) in which the legionellae reside must be taken into account in future studies concerning the intracellular killing of these bacteria.
